The Prescription Pattern and Analyses of Antidepressants under the National Health Insurance Policy in Taiwan

健保制度下抗憂鬱劑的世代分析及處方行為

黃崇恆(Chong-Heng Huang) ； 陳繼明(Chi-Ming Chen) ； 許光陽(Kuang-Yang Hsu) ； 陳麗珍(Lih-Jen C Wang) ； 陳世英(Shih-Ying Chen) ； 李靜芬(Ching-Fen Lee)

《台灣精神醫學》 25卷2期 (2011/06) Pp. 76-85

https://doi.org/10.29478/TJP.201106.0003

並列摘要

Background: In this study, we examined trends associated with various antidepressants competing in the Taiwanese market, based on data from the National Health Insurance (NHI) Research Database. Methods: The cases of patients diagnosed with depression were selected as the subjects of this study. The prescription and use of antidepressants were analyzed to shed light on the competition in the market and substitution of these drugs, as influenced by the NHI insurance system. Results: The data indicated that the number of patients diagnosed with clinical depression was increased twofold and that the associated expenditure on antidepressants was increased threefold between 1997 and 2004. We also observed the total incremental use of antidepressants in each category, indicating that third-generation antidepressants continued to dominate market, and gradually replaced those of the first-generation antidepressants. The use of second-generation antidepressants was found to have remained relatively unchanged. Among all levels of hospital organizations, third-generation antidepressants were found to be preferred. The medical staff at district hospitals and primary care clinics prescribed more first-generation antidepressants than those at regional hospitals or medical centers. Conclusions: The use of third-generation antidepressants has surpassed that of first-and second-generation. The non-free market drug reimbursement mechanism governed by NHI had influence on prescription patterns of antidepressants in hospitals. All aspects of competition among antidepressants are in line with the Porter's theory of competition.

並列關鍵字

Antidepressants ； National Health Insurance Research Database ； drug generation substitution ； drug generation competition

參考文獻

American Psychiatric Association(2000).Diagnostic and Statistical Manual of Mental Disorders.Washington DC:American Psychiatric Association.

World Health Organization(2001).The World Health Report 2001.Geneva:World Health Organization.

Kanter, JW,Rusch, LC,Brondino, MJ(2008).Depression self-stigma: a new measure and preliminary findings.J Nerv Ment Dis.196,663-70.

Georg, Hsu LK,Wan, YM,Chang, H,Summergrad, P,Tsang, BY,Chen, H(2008).Stigma of depression is more severe in Chinese Americans than Caucasian Americans.Psychiatry.71,210-8.

Liu, YM,Kao, YH,Hsieh, CR(2009).Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan.J Health Econ.28,341-9.